Kiran Mazumdar-Shaw is nothing if not innovative.
Starting with a postgraduate degree in brewing from an Australian university, she built the largest biopharmaceutical company in India.
And, along the way, she dispensed with antagonistic unionists by automating her production line; developed and patented a solid substrate bioreactor that facilitated the cultivation and extraction of microorganisms used in the production of industrial enzymes; skirted around international patents with a revolutionary method for manufacturing human insulin in yeast; created new therapies for both psoriasis and cancer of the head and neck; and established a micro-insurance program that has the potential to provide quality health care and medicines to millions of Indian villagers for an annual fee of just $3 per head.
"The difference lies in our DNA"
@blrcitytraffic @carmelaramunite @12 Pls don’t allow right turns on arterial roads. Eg at Madivala police station— Kiran Mazumdar Shaw (@kiranshaw) September 24, 2018
BBC News - 'They were not comfortable about hiring a woman' https://t.co/oJprmmeVz3 I do hope to see more self made… https://t.co/8to6FsQ2Gk— Kiran Mazumdar Shaw (@kiranshaw) September 24, 2018
Good to see women scaling heights— Kiran Mazumdar Shaw (@kiranshaw) September 24, 2018